Cargando…

Special Issue: New Insights into the Pathogenesis and Therapies of IgA Nephropathy

Detalles Bibliográficos
Autores principales:	Suzuki, Hitoshi, Novak, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369139/ https://www.ncbi.nlm.nih.gov/pubmed/35955995 http://dx.doi.org/10.3390/jcm11154378

Ejemplares similares

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

New insights into the pathogenesis of IgA nephropathy
por: Yeo, See Cheng, et al.
Publicado: (2017)

Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis
por: Suzuki, Hitoshi
Publicado: (2018)

New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy
por: Scionti, Katrin, et al.
Publicado: (2021)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Identification of IgA autoantibodies targeting mesangial cells redefines the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

New developments in the genetics, pathogenesis, and therapy of IgA nephropathy
por: Magistroni, Riccardo, et al.
Publicado: (2015)

Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy
por: Nakata, Junichiro, et al.
Publicado: (2014)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy
por: Kano, Toshiki, et al.
Publicado: (2022)

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
por: Placzek, William J., et al.
Publicado: (2018)

IgA nephropathy pathogenesis and therapy: Review & updates
por: Habas, Elmukhtar, et al.
Publicado: (2022)

The Emerging Role of Pathogenesis of IgA Nephropathy
por: Wu, Meng-Yu, et al.
Publicado: (2018)

IgA Nephropathy: Current Treatment and New Insights
por: Petrou, Dimitra, et al.
Publicado: (2023)

Aberrantly Glycosylated IgA1 as a Factor in the Pathogenesis of IgA Nephropathy
por: Tanaka, Mototsugu, et al.
Publicado: (2011)

Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy
por: Yamada, Koshi, et al.
Publicado: (2017)

Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment
por: Knoppova, Barbora, et al.
Publicado: (2021)

The Role of Immune Modulation in Pathogenesis of IgA Nephropathy
por: Chang, Sheng, et al.
Publicado: (2020)

Clinical Significance of the Intensity of Glomerular Galactose-Deficient IgA1 Deposition in IgA Nephropathy
por: Nakayama, Maiko, et al.
Publicado: (2022)

Uncoupling of Glomerular IgA Deposition and Disease Progression in Alymphoplasia Mice with IgA Nephropathy
por: Aizawa, Masashi, et al.
Publicado: (2014)

IgA Nephropathy: A Tale of 3 Continents
por: Tang, Sydney Chi-Wai
Publicado: (2021)

Why Target the Gut to Treat IgA Nephropathy?
por: Barratt, Jonathan, et al.
Publicado: (2020)

Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy
por: Yasutake, Junichi, et al.
Publicado: (2015)

Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy
por: Zachova, Katerina, et al.
Publicado: (2020)

The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
por: Knoppova, Barbora, et al.
Publicado: (2016)

The pathogenesis of COVID-19-induced IgA nephropathy and IgA vasculitis: A systematic review
por: Farooq, Hareem, et al.
Publicado: (2021)

Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis
por: Suzuki, Hitoshi, et al.
Publicado: (2019)

Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy
por: Lee, Mingfeng, et al.
Publicado: (2020)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Utility of remission criteria for the renal prognosis of IgA nephropathy
por: Matsuzaki, Keiichi, et al.
Publicado: (2021)

cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy
por: Misaki, Taro, et al.
Publicado: (2023)

Significance of segmental glomerulosclerosis in IgA nephropathy: What is the evidence?
por: Mubarak, Muhammed, et al.
Publicado: (2013)

Urokinase-type plasminogen activator receptor in IgA nephropathy
por: Ahn, Shin-Young, et al.
Publicado: (2014)

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease
por: Reily, Colin, et al.
Publicado: (2014)

Serial Galactose-Deficient IgA1 Levels in Children with IgA Nephropathy and Healthy Controls
por: Sanders, John T., et al.
Publicado: (2017)

Pathological Role of Tonsillar B Cells in IgA Nephropathy
por: Suzuki, Yusuke, et al.
Publicado: (2011)

A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases
por: Yanagawa, Hiroyuki, et al.
Publicado: (2014)

Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know
por: Ohyama, Yukako, et al.
Publicado: (2021)

Enzymatic Sialylation of IgA1 O-Glycans: Implications for Studies of IgA Nephropathy
por: Takahashi, Kazuo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jbtth9mpd9o4tq3g1c547c2v4n